<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

	<!-- RSS feed defaults -->
	<channel>
		<title>Wyss InstituteDiabetes &#8211; Wyss Institute</title>
		<link>https://wyss.harvard.edu</link>
		<description>Wyss Institute at Harvard</description>
		<lastBuildDate>Mon, 06 Apr 2026 19:50:40 +0000</lastBuildDate>
		<language>en-US</language>
		<sy:updatePeriod>hourly</sy:updatePeriod>
		<sy:updateFrequency>1</sy:updateFrequency>
		<atom:link href="https://wyss.harvard.edu/application-area/diabetes/feed/" rel="self" type="application/rss+xml" />

		<generator>https://wordpress.org/?v=6.7.1</generator>

		<!-- Start loop -->
		
			<item>
				<title>How can we feed the world?</title>
				<link>https://wyss.harvard.edu/media-post/how-can-we-feed-the-world/</link>
        <pubDate>Thu, 11 May 2023 17:14:54 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Food]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?post_type=media_post&#038;p=36797</guid>
                                                <content:encoded><![CDATA[<p>The current agricultural methods of feeding the world are not sustainable and already have dire consequences that will worsen as the Earth&rsquo;s population continues to grow. Researchers at the Wyss Institute are working on various solutions that could help provide food for our future needs with a lower environmental impact. Credit: Wyss Institute at Harvard University&#8230;</p>
<p><a href="https://wyss.harvard.edu/media-post/how-can-we-feed-the-world/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/media-post/how-can-we-feed-the-world/</link>
          <title></title>
					<url>https://wyss-prod.imgix.net/app/uploads/2023/05/11131245/THUMBNAIL_How-can-we-feed-the-world-Impact-Report.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=be9979e45823ed5d8829b23822ce57ce"/></url>
				</image>
        			</item>

		
			<item>
				<title>Adama Sesay on Solving Problems with Sensors and Microsystems</title>
				<link>https://wyss.harvard.edu/news/humans-of-the-wyss-adama-sesay-on-solving-problems-with-sensors-and-microsystems/</link>
        <pubDate>Thu, 30 Mar 2023 13:07:13 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Community]]></category>
		<category><![CDATA[Blood clotting]]></category>
		<category><![CDATA[Humans of the Wyss]]></category>
		<category><![CDATA[Immune System]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=36170</guid>
                                                <content:encoded><![CDATA[<p>The Humans of the Wyss (HOW) series features members of the Wyss community discussing their work, the influences that shape them as scientists, and their collaborations at the Wyss Institute and beyond. If you had asked Adama Sesay as a child what she wanted to be when she grew up, the answer would have been a doctor, an architect, and a firefighter. Now a Senior Engineer specializing in&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/humans-of-the-wyss-adama-sesay-on-solving-problems-with-sensors-and-microsystems/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/humans-of-the-wyss-adama-sesay-on-solving-problems-with-sensors-and-microsystems/</link>
          <title>Adama Sesay, Senior Engineer II. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2023/03/22102626/WoW-Adama-Sesay-Neutral-1521.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=49ef1af8132daaf3f08349e601e0b65b"/></url>
				</image>
        			</item>

		
			<item>
				<title>Vaskar Gnyawali on Bringing Science to Life</title>
				<link>https://wyss.harvard.edu/news/humans-of-the-wyss-vaskar-gnyawali-on-bringing-science-to-life/</link>
        <pubDate>Wed, 20 Apr 2022 14:04:54 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Community]]></category>
		<category><![CDATA[Humans of the Wyss]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=32231</guid>
                                                <content:encoded><![CDATA[<p>The Humans of the Wyss (HOW) series features members of the Wyss community discussing their work, the influences that shape them as scientists, and their collaborations at the Wyss Institute and beyond. Early in his professional life, Vaskar Gnyawali realized he wasn&rsquo;t content sitting in front of a computer screen all day, so he shifted from software engineering to microsystems engineering. Now&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/humans-of-the-wyss-vaskar-gnyawali-on-bringing-science-to-life/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/humans-of-the-wyss-vaskar-gnyawali-on-bringing-science-to-life/</link>
          <title>Vaskar Gnyawali, Postdoctoral Fellow. Credit: Wyss Institute at Harvard Univeristy</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2022/04/18160716/HoW-Vaskar-Gnyawali-1051112.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=29e5dcd2c7e71d8ee3fd6b5269ff17d6"/></url>
				</image>
        			</item>

		
			<item>
				<title>Rapid Metabolite-Sensing System for Blood Lactate</title>
				<link>https://wyss.harvard.edu/technology/rapid-metabolite-sensing-system-for-blood-lactate/</link>
        <pubDate>Wed, 02 Sep 2020 20:58:10 +0000</pubDate>
        <dc:creator><![CDATA[admin]]></dc:creator>
        		<category><![CDATA[Biosensors]]></category>
		<category><![CDATA[Blood]]></category>
		<category><![CDATA[Cardiovascular Dysfunction]]></category>
		<category><![CDATA[David J. Mooney]]></category>
		<category><![CDATA[Harvard SEAS]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?post_type=technology&#038;p=25831</guid>
                                                <content:encoded><![CDATA[<p>In emergency medicine, blood lactate levels are a reliable real&#x2d;time indicator of the severity and mortality risk of conditions that occur as a result of poor blood circulation and oxygen supply to organs and tissues (hypoperfusion), such as in patients with sepsis, cardiac arrest, stroke, major trauma, cystic fibrosis and other conditions. Lactate levels also provide an early measure for the&#8230;</p>
<p><a href="https://wyss.harvard.edu/technology/rapid-metabolite-sensing-system-for-blood-lactate/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/technology/rapid-metabolite-sensing-system-for-blood-lactate/</link>
          <title>This scanning electron cryomicroscopic (CryoSEM) image shows the size and morphology of lactate-sensing liposomes produced by the approach. Credit: Wyss Institute at Harvard University.</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2020/09/02103144/P2_CryoSEM_22_purple.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=04f73d67b11e286e7071bb144f73a92a"/></url>
				</image>
        			</item>

		
			<item>
				<title>Combination gene therapy treats multiple age-related diseases in mice</title>
				<link>https://wyss.harvard.edu/news/combination-gene-therapy-treats-multiple-age-related-diseases/</link>
        <pubDate>Mon, 04 Nov 2019 19:56:01 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Research Spotlights]]></category>
		<category><![CDATA[Adeno-Associated Virus (AAV)]]></category>
		<category><![CDATA[Anti-aging]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Gene Expression]]></category>
		<category><![CDATA[Gene Therapy]]></category>
		<category><![CDATA[George Church]]></category>
		<category><![CDATA[Harvard Medical School]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=22508</guid>
                            <description>Treatment increases healthspan in mice and could lead to increased longevity therapies </description>
                                        <content:encoded><![CDATA[<p>By Lindsay Brownell (BOSTON) &mdash; As we age, our bodies tend to develop diseases like heart failure, kidney failure, diabetes, and obesity, and the presence of any one disease increases the risk of developing others. In traditional drug development, a drug usually only targets one condition, largely ignoring the interconnectedness of age&#x2d;related diseases, such as obesity, diabetes&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/combination-gene-therapy-treats-multiple-age-related-diseases/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/combination-gene-therapy-treats-multiple-age-related-diseases/</link>
          <title>The AAV-based gene therapy improved the function of the heart and other organs in mice with various age-related diseases, suggesting that such an approach could help maintain health during aging. Credit: Adobe Stock</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2019/11/01092950/AdobeStock_195435366.jpeg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=04539a8aab1da7bb640e705467e7a4ce"/></url>
				</image>
        			</item>

		
			<item>
				<title>Discovery of performance-enhancing bacteria in the human microbiome</title>
				<link>https://wyss.harvard.edu/news/discovery-of-performance-enhancing-bacteria-in-the-human-microbiome/</link>
        <pubDate>Mon, 24 Jun 2019 14:58:38 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Athletic]]></category>
		<category><![CDATA[DNA sequencing]]></category>
		<category><![CDATA[George Church]]></category>
		<category><![CDATA[Harvard Medical School]]></category>
		<category><![CDATA[Metabolic Engineering]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=20888</guid>
                            <description>A single microbe accumulating in the microbiome of elite athletes can enhance exercise performance in mice, paving the way to highly-validated performance-enhancing probiotics</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &ndash; The human microbiome, the vast collection of microbes that colonize the surfaces lining many of our organs and our skin &ndash; is a critical pillar sustaining our general health. At any one time, 500 to 1,000 different species of bacteria inhabit us, which together contain far more genes than our human genome. Researchers have also come to realize that no two&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/discovery-of-performance-enhancing-bacteria-in-the-human-microbiome/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/discovery-of-performance-enhancing-bacteria-in-the-human-microbiome/</link>
          <title>A collaborative team at the Wyss Institute, Havard Medical School and Joslin Diabetes Center identified a performance-enhancing microbe in the gut microbiome of 2015 Boston Marathon runners. Credit: iStock/ZamoraA </title>
					<url>https://wyss-prod.imgix.net/app/uploads/2019/06/21170156/Marathon-Runnging_iStock-506979575.jpeg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=3c584947ea10eb8ec26eac7bc0cb1215"/></url>
				</image>
        			</item>

		
			<item>
				<title>Renal reabsorption in living devices</title>
				<link>https://wyss.harvard.edu/news/renal-reabsorption-in-living-devices/</link>
        <pubDate>Mon, 04 Mar 2019 19:57:05 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Research Spotlights]]></category>
		<category><![CDATA[3D Bioprinting]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Harvard SEAS]]></category>
		<category><![CDATA[Jennifer A. Lewis]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=19603</guid>
                            <description>3D bioprinted, vascularized proximal tubules mimic the human kidney’s reabsorption functions</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (CAMBRIDGE, Mass.) &mdash; Every day our kidneys tackle the daunting task of continuously cleaning our blood to prevent waste, salt and excess fluid from building up inside our bodies. To achieve this, the kidneys&rsquo; approximately one million filtration units (glomeruli) first remove both waste products and precious nutrients from the blood stream&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/renal-reabsorption-in-living-devices/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/renal-reabsorption-in-living-devices/</link>
          <title></title>
					<url>https://wyss-prod.imgix.net/app/uploads/2019/03/01093942/Vascularized-Proximal-Tubule.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=ea969d7d10ccbf17d03d8c28c8921076"/></url>
				</image>
        			</item>

		
			<item>
				<title>Delivering insulin in a pill</title>
				<link>https://wyss.harvard.edu/news/delivering-insulin-in-a-pill/</link>
        <pubDate>Mon, 25 Jun 2018 18:59:01 +0000</pubDate>
        <dc:creator><![CDATA[Mariel Schoen]]></dc:creator>
        		<category><![CDATA[Research Spotlights]]></category>
		<category><![CDATA[Harvard SEAS]]></category>
		<category><![CDATA[Samir Mitragotri]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=16323</guid>
                            <description>Technique could replace daily injections for diabetics</description>
                                        <content:encoded><![CDATA[<p>By Leah Burrows, SEAS Communications (CAMBRIDGE, Mass.) &mdash; Given the choice of taking a pill or injecting oneself with a needle, most of us would opt to regulate a chronic health condition by swallowing a pill. But for the millions of people living with type 1 diabetes, a painful needle prick once or twice daily is the only option for delivering the insulin that their bodies cannot produce on&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/delivering-insulin-in-a-pill/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/delivering-insulin-in-a-pill/</link>
          <title>A new formulation of insulin suspends it in an ionic liquid consisting of food-safe choline and geranic acid, and packages it into a capsule with an acid-resistant enteric coating. This approach could replace the daily insulin injections that millions of diabetics worldwide have to endure, while also improving patients’ adherence to treatment. Credit: Harvard SEAS</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2018/06/25144229/Ionic_Liquid_Image.png?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=bb6bef46c58585bcb92c1f6db6d233ac"/></url>
				</image>
        			</item>

		
			<item>
				<title>Disruptive: Cancer Vaccine and Immuno-Materials</title>
				<link>https://wyss.harvard.edu/media-post/disruptive-cancer-vaccine-and-immuno-materials/</link>
        <pubDate>Tue, 24 Oct 2017 13:50:47 +0000</pubDate>
        <dc:creator><![CDATA[Lucy Thomas]]></dc:creator>
        		<category><![CDATA[David J. Mooney]]></category>
		<category><![CDATA[Wyss Podcast: Disruptive]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?post_type=media_post&#038;p=13052</guid>
                                                <content:encoded><![CDATA[<p>Immunotherapy &ndash; treatment that uses the body&rsquo;s own immune system to help fight disease &ndash; has groundbreaking and life&#x2d;saving implications. In an effort to make immunotherapy more effective, Wyss Institute researchers are developing new immuno&#x2d;materials, which help modulate immune cells to treat or diagnose disease. In this episode of Disruptive, Dave Mooney, Wyss Core Faculty member&#8230;</p>
<p><a href="https://wyss.harvard.edu/media-post/disruptive-cancer-vaccine-and-immuno-materials/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/media-post/disruptive-cancer-vaccine-and-immuno-materials/</link>
          <title></title>
					<url>https://wyss-prod.imgix.net/app/uploads/2017/10/06082312/Disruptive-Immuno-Therapy-e1535560526692.jpeg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=29e79fc72f677795cbb0410ad2591e4f"/></url>
				</image>
        			</item>

		
			<item>
				<title>Introducing ‘Immuno-Materials’ to immunotherapy</title>
				<link>https://wyss.harvard.edu/news/introducing-immuno-materials-to-immunotherapy/</link>
        <pubDate>Wed, 23 Aug 2017 13:34:07 +0000</pubDate>
        <dc:creator><![CDATA[Mariel Schoen]]></dc:creator>
        		<category><![CDATA[Research Spotlights]]></category>
		<category><![CDATA[David J. Mooney]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=11079</guid>
                            <description>In the Wyss Institute’s ‘Immuno-Materials’ Focus Area, institute researchers develop material-based systems capable of manipulating immune cells in the human body to treat or diagnose disease</description>
                                        <content:encoded><![CDATA[<p>Dysfunction of the immune system underlies many diseases, including cancer and autoimmune disease. Further, it is increasingly recognized that immune cells actively regulate tissue regeneration. Advances in our understanding of the human innate and adaptive immune systems thus promise to revolutionize the treatments of many diseases. However, strategies to effectively program an immune response&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/introducing-immuno-materials-to-immunotherapy/" rel="nofollow">Source</a></p>]]></content:encoded>
                          			</item>

			</channel>
</rss>
